These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37440784)

  • 1. Effect of
    Cancer Manag Res; 2023; 15():625-626. PubMed ID: 37440784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of
    Wu X; Xu Q; Chen P; Yu C; Ye L; Huang C; Li T
    Cancer Manag Res; 2019; 11():8125-8133. PubMed ID: 31564972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated placental histone H3K4 methylation via upregulated histone methyltransferases SETD1A and SMYD3 in preeclampsia and its possible involvement in hypoxia-induced pathophysiological process.
    Matsui H; Iriyama T; Sayama S; Inaoka N; Suzuki K; Yoshikawa M; Ichinose M; Sone K; Kumasawa K; Nagamatsu T; Fujisawa T; Naguro I; Ichijo H; Fujii T; Osuga Y
    Placenta; 2021 Nov; 115():60-69. PubMed ID: 34560329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y; Fan Y
    Tumour Biol; 2016 Jun; 37(6):7371-81. PubMed ID: 26676636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of
    Cancer Manag Res; 2021; 13():9421-9422. PubMed ID: 35002319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance and Effect of MTDH/AEG-I in Bladder Urothelial Cancer: A Study Based on Immunohistochemistry, RNA-Seq, and in vitro Verification [Retraction].
    Cancer Manag Res; 2020; 12():461. PubMed ID: 32021458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction].
    Cancer Manag Res; 2023; 15():1267-1268. PubMed ID: 38027244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction].
    Cancer Manag Res; 2022; 14():2105-2106. PubMed ID: 35769227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Cancer Manag Res; 2022; 14():1741-1742. PubMed ID: 35607446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction].
    Cancer Manag Res; 2022; 14():3525-3526. PubMed ID: 36579352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Down-Regulation of TrkB Alleviates the Malignant Biological Behavior and Cancer Stem-Like Property of Laryngeal Cancer [Retraction].
    Cancer Manag Res; 2024; 16():639-640. PubMed ID: 38912516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p [Retraction].
    Cancer Manag Res; 2023; 15():739-740. PubMed ID: 37489174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression.
    Chen YJ; Tsai CH; Wang PY; Teng SC
    Sci Rep; 2017 Jun; 7(1):3842. PubMed ID: 28630472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer [Retraction].
    Cancer Manag Res; 2023; 15():1265-1266. PubMed ID: 38027243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
    Cock-Rada AM; Medjkane S; Janski N; Yousfi N; Perichon M; Chaussepied M; Chluba J; Langsley G; Weitzman JB
    Cancer Res; 2012 Feb; 72(3):810-20. PubMed ID: 22194464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD3: a regulator of epigenetic and signaling pathways in cancer.
    Bernard BJ; Nigam N; Burkitt K; Saloura V
    Clin Epigenetics; 2021 Feb; 13(1):45. PubMed ID: 33637115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression [Retraction].
    Cancer Manag Res; 2021; 13():7495-7496. PubMed ID: 34611445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role and Mechanism of S1PR5 in Colon Cancer [Retraction].
    Cancer Manag Res; 2021; 13():5723. PubMed ID: 34290529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
    Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
    J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.